Key toolkits of non-pharmacological management in COPD: during and beyond COVID-19

Alqahtani, Jaber S; Alghamdi, Saeed M; Aldhahir, Abdulelah M.; Althobiani, Malik; Oyelade, Tope

doi:10.52586/4938

Cited by 8 publications

(3 citation statements)

References 56 publications

(85 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This supports an earlier study by Hurst et al (2021), which showed that a significant number of people living with chronic lung disease believed that anti-infection measures should be applied to the wider community as well as to themselves beyond the COIVD-19 pandemic, particularly during the flu season [18]. For the future implementation of such measures among smokers and people living with chronic lung disease, special consideration should be paid to the benefits and potential harms of these measures, including cost and psychological harm [18,30].…”

Section: Discussionmentioning

confidence: 99%

Future Acceptability of Respiratory Virus Infection Control Interventions in General Population to Prevent Respiratory Infections

et al. 2022

View full text Add to dashboard Cite

Background and Objectives: In both pandemic and non-pandemic situations, nonpharmaceutical public health measures may offer easy, low-cost, and effective means of reducing the spread and impact of acute respiratory infections. It is unknown whether such measures would be acceptable to the Saudi community beyond the current pandemic. Materials and Methods: A validated survey was used to test community acceptance of the measures. Respondents were asked which infection control practices they planned to maintain and which they believed should be policies for the community as a whole after the COVID-19 pandemic has subsided. Results: The survey was completed by 2057 people (95% completion rate), 1486 (72%) of whom were female, 259 (12.5%) of whom were current smokers, and 72 (3.5%) of whom had chronic lung disease. The most prevalent age groups were 18–30 years (933; 45.4%) and 31–40 years (483; 23.5%), with 641 individuals over 40 years old. Of the responses, 93% indicated that they would continue washing their hands more often; 92% wanted both clinicians and patients to wear masks in hospitals; 86% would continue avoiding smoking in indoor and outdoor areas; 73% would continue wearing a face covering on public transportation; 70% indicated that they would continue wearing a face covering in indoor public places. Regarding the respiratory virus infection control measures, 85% (11/13) received significant support (≥70% acceptability level) for continuation as policies in the future. Wearing face coverings outdoors and social distancing outdoors received little support (45% and 66%, respectively). Of the respiratory virus infection control measures, 54% received less support from current smokers than non-smokers (acceptability level < 70%). People with chronic respiratory disease supported 77% of the measures being regarded as policies in the future. Conclusion: The Saudi community supports nonpharmacological respiratory infection control measures that reduce the likelihood of infection. Public health campaigns should target smokers to increase awareness of the importance of these measures in lowering infections. Based on the findings of this study, nonpharmacological treatments should be presented and included in future recommendations for both the public and patients diagnosed with chronic respiratory diseases.

show abstract

Section: Discussionmentioning

confidence: 99%

Future Acceptability of Respiratory Virus Infection Control Interventions in General Population to Prevent Respiratory Infections

et al. 2022

View full text Add to dashboard Cite

show abstract

“…The biological explanation could be the upregulation of the angiotensin-converting enzyme 2 receptors and the epithelial damage present in COPD patients and smokers. Another explanation is more mechanistic and involves hand-to-face movement, which would accelerate viral transmission [ 93 ], making the care of COPD patients with COVID-19 particularly challenging.…”

Section: Smoking Cessation During the Coronavirus Disease 2019 Pandem...mentioning

confidence: 99%

Smoking cessation and vaccination

Laucho-Contreras

2023

Eur Respir Rev

View full text Add to dashboard Cite

A significant proportion of COPD patients (∼40%) continue smoking despite knowing that they have the disease. Smokers with COPD exhibit higher levels of nicotine dependence, and have lower self-efficacy and self-esteem, which affects their ability to quit smoking. Treatment should be adapted to the needs of individual patients with different levels of tobacco dependence. The combination of counselling plus pharmacotherapy is the most effective cessation treatment for COPD. In patients with severe COPD, varenicline and bupropion have been shown to have the highest abstinence rates compared with nicotine replacement therapy. There is a lack of evidence to support that smoking cessation reduction or harm reduction strategies have benefits in COPD patients. The long-term efficacy and safety of electronic cigarettes for smoking cessation need to be evaluated in high-risk populations; therefore, it is not possible to recommend their use for smoking cessation in COPD. Future studies with the new generation of nicotine vaccines are necessary to determine their effectiveness in smokers in general and in COPD patients.

show abstract

“…Pharmacological treatments such as bronchodilators, expectorants, antibiotics, and inhaled corticosteroids assist in controlling symptoms [3]. In parallel with non-pharmacological treatments, such as smoking cessation, pulmonary rehabilitation (PR), and vaccination, which play a role in self-management as well as maintaining and controlling the condition [4]. Technology can play an important role in facilitating the delivery of these treatments, promoting self-management.…”

Section: Introductionmentioning

confidence: 99%

Content, Mechanism, and Outcome of Effective Telehealth Solutions for Management of Chronic Obstructive Pulmonary Diseases: A Narrative Review

Alghamdi

2023

Healthcare

View full text Add to dashboard Cite

Telehealth (TH) solutions for Chronic Obstructive Pulmonary Disease (COPD) are promising behavioral therapeutic interventions and can help individuals living with COPD to improve their health status. The linking content, mechanism, and outcome of TH interventions reported in the literature related to COPD care are unknown. This paper aims to summarize the existing literature about structured TH solutions in COPD care. We conducted an electronic search of the literature related to TH solutions for COPD management up to October 2023. Thirty papers presented TH solutions as an innovative treatment to manage COPD. TH and digital health solutions are used interchangeably in the literature, but both have the potential to improve care, accessibility, and quality of life. To date, current TH solutions in COPD care have a variety of content, mechanisms, and outcomes. TH solutions can enhance education as well as provide remote monitoring. The content of TH solutions can be summarized as symptom management, prompt physical activity, and psychological support. The mechanism of TH solutions is manipulated by factors such as content, mode of delivery, strategy, and intensity. The most common outcome measures with TH solutions were adherence to treatment, health status, and quality of life. Implementing effective TH with a COPD care bundle must consider important determinants such as patient’s needs, familiarity with the technology, healthcare professional support, and data privacy. The development of effective TH solutions for COPD management also must consider patient engagement as a positive approach to optimizing implementation and effectiveness.

show abstract

Key toolkits of non-pharmacological management in COPD: during and beyond COVID-19

Cited by 8 publications

References 56 publications

Future Acceptability of Respiratory Virus Infection Control Interventions in General Population to Prevent Respiratory Infections

Future Acceptability of Respiratory Virus Infection Control Interventions in General Population to Prevent Respiratory Infections

Smoking cessation and vaccination

Content, Mechanism, and Outcome of Effective Telehealth Solutions for Management of Chronic Obstructive Pulmonary Diseases: A Narrative Review

Contact Info

Product

Resources

About